Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Transfusion ; 55(6): 1155-68, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25556331

RESUMEN

BACKGROUND: In most countries, red blood cells (RBCs) can be stored up to 42 days before transfusion. However, observational studies have suggested that storage duration might be associated with increased morbidity and mortality. While clinical trials are under way, impaired metabolism has been documented in RBCs stored in several additive solutions (ASs). Here we hypothesize that, despite reported beneficial effects, storage in AS-3 results in metabolic impairment weeks before the end of the unit shelf life. STUDY DESIGN AND METHODS: Five leukofiltered AS-3 RBC units were sampled before, during, and after leukoreduction Day 0 and then assayed on a weekly basis from storage Day 1 through Day 42. RBC extracts and supernatants were assayed using a ultra-high-performance liquid chromatography separations coupled online with mass spectrometry detection metabolomics workflow. RESULTS: Blood bank storage significantly affects metabolic profiles of RBC extracts and supernatants by Day 14. In addition to energy and redox metabolism impairment, intra- and extracellular accumulation of amino acids was observed proportionally to storage duration, suggesting a role for glutamine and serine metabolism in aging RBCs. CONCLUSION: Metabolomics of stored RBCs could drive the introduction of alternative ASs to address some of the storage-dependent metabolic lesions herein reported, thereby increasing the quality of transfused RBCs and minimizing potential links to patient morbidity.


Asunto(s)
Adenina/farmacología , Conservación de la Sangre , Citratos/farmacología , Eritrocitos/efectos de los fármacos , Glucosa/farmacología , Metaboloma/efectos de los fármacos , Soluciones Preservantes de Órganos/farmacología , Fosfatos/farmacología , Cloruro de Sodio/farmacología , Adulto , Cromatografía Líquida de Alta Presión , Frío , Transfusión de Eritrocitos , Eritrocitos/metabolismo , Humanos , Soluciones Isotónicas/farmacología , Factores de Tiempo
2.
Nat Neurosci ; 18(5): 683-9, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25849987

RESUMEN

An essential feature of vertebrate neural development is ensheathment of axons with myelin, an insulating membrane formed by oligodendrocytes. Not all axons are myelinated, but mechanisms directing myelination of specific axons are unknown. Using zebrafish, we found that activity-dependent secretion stabilized myelin sheath formation on select axons. When VAMP2-dependent exocytosis was silenced in single axons, oligodendrocytes preferentially ensheathed neighboring axons. Nascent sheaths formed on silenced axons were shorter in length, but when activity of neighboring axons was also suppressed, inhibition of sheath growth was relieved. Using in vivo time-lapse microscopy, we found that only 25% of oligodendrocyte processes that initiated axon wrapping were stabilized during normal development and that initiation did not require activity. Instead, oligodendrocyte processes wrapping silenced axons retracted more frequently. We propose that axon selection for myelination results from excessive and indiscriminate initiation of wrapping followed by refinement that is biased by activity-dependent secretion from axons.


Asunto(s)
Potenciales de Acción/fisiología , Axones/ultraestructura , Vaina de Mielina/fisiología , Oligodendroglía/fisiología , Animales , Animales Modificados Genéticamente , Axones/metabolismo , Exocitosis/efectos de los fármacos , Genes Reporteros , Proteínas Fluorescentes Verdes/análisis , Proteínas Fluorescentes Verdes/genética , Proteínas de Homeodominio/análisis , Proteínas de Homeodominio/genética , Microscopía Confocal , Vaina de Mielina/efectos de los fármacos , Neurogénesis , Canales de Potasio de Rectificación Interna/genética , Canales de Potasio de Rectificación Interna/fisiología , Proteínas Recombinantes de Fusión/metabolismo , Médula Espinal/citología , Médula Espinal/efectos de los fármacos , Médula Espinal/crecimiento & desarrollo , Vesículas Sinápticas/efectos de los fármacos , Vesículas Sinápticas/fisiología , Tetrodotoxina/farmacología , Imagen de Lapso de Tiempo , Factores de Transcripción/análisis , Factores de Transcripción/genética , Veratridina/farmacología , Pez Cebra/embriología
3.
Toxicol In Vitro ; 29(1): 187-94, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25458488

RESUMEN

Gold nanoparticles (AuNPs) are promising candidates for medical diagnostics and therapeutics, due to their chemical stability, optical properties, and ease of functionalization. Citrate-stabilized reference materials also have potential as negative controls in toxicology studies of other nanoparticles. Here we examine the impact of 30 nm particles on the in vitro development of rat-cortex neural progenitor cells (NPCs), which mimic aspects of the developing neurological environment. AuNPs dispersed in a low serum culture medium initially agglomerated, but then remained stable during a three day incubation period, and agglomerated only slightly during a ten day incubation period, as determined by dynamic light scattering. Transmission electron microscopy indicated the presence of individual nanoparticles at all time points examined. Fixed cells were cross-sectioned by ion milling and imaged by scanning electronmicroscopy and helium-ion microscopy to evaluate particle incorporation. Individual nanoparticles could be resolved inside cross-sectioned cells. AuNPs were incubated with developing NPCs for ten days at concentrations of 0.5 µg/mL Au, 0.1 µg/mL Au, or 0.05 µg/mL Au. Adenosine triphosphate levels, as determined by bioluminescence measurements sensitive to low cell numbers, were not affected by AuNPs and the particles did not interfere with the assay. Multiple endpoints of neurite outgrowth were not altered by AuNPs, in particular, total neurite outgrowth per cell, a sensitive measure of neuronal development. Slide-level comparisons demonstrated the consistent response of NPCs to gold nanoparticles and a positive control chemical, neuroactive lithium. These results indicate that 30 nm citrate-stabilized AuNPs could serve as negative-control reference materials for in vitro measurements of neurite outgrowth.


Asunto(s)
Oro , Nanopartículas del Metal , Neuritas/fisiología , Adenosina Trifosfato/análisis , Animales , Ácido Cítrico , Oro/efectos adversos , Nanopartículas del Metal/efectos adversos , Microscopía Electrónica de Rastreo , Microscopía Electrónica de Transmisión , Células-Madre Neurales/química , Células-Madre Neurales/efectos de los fármacos , Células-Madre Neurales/fisiología , Neuritas/química , Neuritas/efectos de los fármacos , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA